Dr. Chetan Kalal — Hepatologist and Liver Transplant Specialist in Mumbai
Quick Summary: Dr. Chetan Kalal is a Mumbai-based Hepatologist and Liver Transplant Specialist affiliated with Sir H. N. Reliance Foundation Hospital. His core expertise includes advanced liver cirrhosis treatment, acute-on-chronic liver failure management, and liver transplant evaluation, with focused care for chronic liver disease, viral hepatitis, and MASLD/MASH.
Why Choose Dr. Chetan Kalal for Liver Care?
Choosing the right liver specialist matters when a diagnosis involves jaundice, cirrhosis, ascites, liver cancer risk, liver failure, or the possibility of transplant. Dr. Chetan Kalal offers subspecialty hepatology-led care for patients who need precise diagnosis, evidence-based treatment, and timely escalation to liver intensive care or transplant pathways.
Specialist hepatology training: Dr. Kalal is publicly listed as MBBS, MD Medicine, and DM Hepatology, with focused expertise in hepatology and liver transplantation. (drchetankalal)
Advanced liver disease care: His clinical focus includes chronic liver disease, liver cirrhosis treatment, portal hypertension, acute liver failure, acute-on-chronic liver failure, and liver transplantation. (drchetankalal)
Transplant-oriented decision-making: Patients with decompensated cirrhosis, recurrent ascites, hepatic encephalopathy, kidney dysfunction, or ACLF need rapid pre-transplant workup, donor assessment, ICU coordination, and risk stratification.
Academic authority: Public profiles describe research activity in liver disease, ACLF, refractory ascites, and drug- or herb-induced liver injury, with participation in scientific publications and hepatology forums. (Justdial)
Mumbai-based tertiary care access: Dr. Kalal is listed in connection with specialist liver services in Mumbai, including hepatology, HPB surgery, and transplant-linked care. (drchetankalal)
Comprehensive Liver Disease Treatment in Mumbai
Chronic Liver Disease and Liver Cirrhosis Treatment
Chronic liver disease may progress silently for years before patients develop ascites, variceal bleeding, jaundice, muscle loss, confusion, or kidney dysfunction. Dr. Kalal’s approach emphasizes early diagnosis, fibrosis staging, nutrition, portal hypertension assessment, and individualized liver cirrhosis treatment to prevent decompensation.
Care commonly includes FibroScan or liver elastography, viral hepatitis testing, autoimmune and metabolic evaluation, alcohol-related liver disease management, endoscopy for varices, ascites control, and transplant referral when liver reserve is critically reduced.
MASLD/MASH and Fatty Liver Disease Care
Metabolic-associated steatotic liver disease, now called MASLD, and its inflammatory form MASH are rising causes of cirrhosis and liver cancer. Patients with diabetes, obesity, dyslipidemia, hypertension, or abnormal liver enzymes need structured risk stratification rather than reassurance based on ultrasound alone.
Dr. Kalal’s liver-focused MASLD/MASH care prioritizes fibrosis risk, cardiometabolic optimization, weight management, sarcopenia prevention, and surveillance for cirrhosis complications when advanced fibrosis is suspected.
Acute-on-Chronic Liver Failure and Liver Intensive Care
Acute-on-chronic liver failure is a medical emergency in which a patient with chronic liver disease develops sudden liver failure with kidney, brain, circulatory, respiratory, or coagulation dysfunction. ACLF requires urgent hepatology-led triage, infection control, renal support, nutrition, encephalopathy management, and transplant decision-making.
Patients with rapidly rising bilirubin, INR prolongation, altered sensorium, sepsis, low urine output, severe alcoholic hepatitis, drug-induced liver injury, or acute viral hepatitis on cirrhosis should seek immediate liver intensive care evaluation.
Viral Hepatitis and Pre-Transplant Workup
Hepatitis B and hepatitis C remain treatable but potentially serious causes of cirrhosis, liver cancer, and transplant need. Modern antiviral therapy can suppress or cure infection, but patients with advanced fibrosis require ongoing surveillance.
For patients approaching transplant, pre-transplant workup includes liver disease severity scoring, cardiac and renal assessment, infection screening, nutrition evaluation, donor feasibility, cancer surveillance, and counseling for family members.
Answers to Common Liver Health Questions
When should you see a hepatologist vs. a gastroenterologist?
See a hepatologist when liver tests remain abnormal, FibroScan suggests fibrosis, cirrhosis is suspected, or complications such as ascites, jaundice, varices, encephalopathy, hepatitis B/C, fatty liver with fibrosis, ACLF, or transplant evaluation are present. Early referral can prevent avoidable decompensation.
Persistent abnormal liver enzymes
Suspected cirrhosis or portal hypertension
Need for transplant or ACLF care
What are warning signs that liver cirrhosis is becoming serious?
Cirrhosis becomes urgent when swelling of the abdomen or legs, vomiting blood, black stools, confusion, sleep reversal, jaundice, fever, severe weakness, weight loss, low urine output, or worsening kidney tests occur. These signs may indicate decompensation or ACLF.
Ascites, bleeding, or confusion
Jaundice with fever or kidney dysfunction
Immediate hepatology review needed
How is MASLD/MASH different from simple fatty liver?
Simple fatty liver means fat is present in the liver, often without advanced scarring. MASH includes inflammation and injury that can progress to fibrosis, cirrhosis, liver cancer, and transplant need. Risk is higher with diabetes, obesity, and metabolic syndrome.
Fibrosis staging is essential
Diabetes increases progression risk
Weight loss must preserve muscle
When is liver transplant evaluation needed?
Liver transplant evaluation is needed when cirrhosis causes recurrent ascites, variceal bleeding, encephalopathy, kidney dysfunction, repeated hospitalizations, liver cancer within transplant criteria, or ACLF. Referral should occur before the patient becomes too frail for surgery.
Recurrent decompensation
MELD or ACLF deterioration
Early pre-transplant workup improves readiness
Book a Liver Consultation in Mumbai
Liver disease can change quickly, especially when cirrhosis, jaundice, ascites, ACLF, viral hepatitis, or transplant questions are involved. For patients and families facing uncertainty, a timely hepatology consultation can clarify diagnosis, stabilize risk, and guide the next safe step.
Book a consultation with Dr. Chetan Kalal in Mumbai for expert evaluation of chronic liver disease, MASLD/MASH, liver cirrhosis, ACLF, viral hepatitis, liver intensive care needs, and pre-transplant workup.
